Siemens Atellica CH CK_L Creatine Kinase Reagent Recall

Siemens Healthcare Diagnostics is conducting a targeted lot removal of its Atellica CH CK_L (Creatine Kinase) reagent due to identified safety or quality concerns. The recall covers 847 units, with affected laboratories receiving direct notification from the manufacturer including return/replacement instructions.

Medical biology laboratories in possession of affected units must immediately cease using the recalled reagent for patient testing and follow Siemens Healthcare Diagnostics instructions for returning or replacing the product. Laboratories that have already performed tests using the affected reagent should assess potential impact on patient results and consider appropriate follow-up measures. Failure to address a medical device recall could result in unreliable diagnostic results with direct patient safety implications.